𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tremor/Ataxia syndrome in fragile X carrier males

✍ Scribed by Maureen A. Leehey; Randi J. Hagerman; William M. Landau; Jim Grigsby; Flora Tassone; Paul J. Hagerman


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
78 KB
Volume
17
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Fragile X-associated Tremor/Ataxia Syndr
✍ Hagerman, Paul J. ;Hagerman, Randi J. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Carriers of fragile X mental retardation 1 (__FMR1__) premutation alleles (55 to 200 CGG repeats) are generally spared the more serious neurodevelopmental problems associated with the full‐mutation carriers (>200 repeats) of fragile X syndrome. However, some adult male premutation carri

Intrafamilial variability in fragile X–a
✍ Nils Peters; Christoph Kamm; Friedrich Asmus; Elke Holinski-Feder; Eduard Kraft; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract Fragile X–associated tremor/ataxia syndrome (FXTAS) is a progressive adult‐onset tremor/ataxia syndrome caused by premutations in the __FMR1__ gene. In cranial MRI, the most characteristic findings are bilateral T2 hyperintense lesions within the middle cerebellar peduncles. Here we pre

Impairment of executive cognitive functi
✍ Jim Grigsby; Angela G. Brega; Maureen A. Leehey; Glenn K. Goodrich; Sébastien Ja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The fragile X‐associated tremor/ataxia syndrome (FXTAS) is a recently identified phenotype associated with trinucleotide repeat expansions in the premutation range of the fragile X mental retardation 1 (__FMR1__) gene. In addition to progressive gait ataxia, action tremor, peripheral ne

Symptomatic treatment in the fragile X–a
✍ Deborah A. Hall; Elizabeth Berry-Kravis; Randi J. Hagerman; Paul J. Hagerman; Ca 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

## Abstract There is no established treatment for the neurological features of the recently discovered fragile X–associated tremor/ataxia syndrome (FXTAS). Fifty‐six patients with FXTAS completed a questionnaire to determine whether any medications had been effective for neurological symptoms. Of 1